BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32814359)

  • 1. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokines CCL5 and CXCL12 exhibit high-affinity binding to N-terminal peptides of the non-cognate receptors CXCR4 and CCR5, respectively.
    Kessler N; Akabayov SR; Cohen LS; Scherf T; Naider F; Anglister J
    FEBS J; 2024 Feb; 291(3):458-476. PubMed ID: 37997026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The solution structure of monomeric CCL5 in complex with a doubly sulfated N-terminal segment of CCR5.
    Abayev M; Rodrigues JPGLM; Srivastava G; Arshava B; Jaremko Ł; Jaremko M; Naider F; Levitt M; Anglister J
    FEBS J; 2018 Jun; 285(11):1988-2003. PubMed ID: 29619777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of intermolecular transferred-NOE interactions in small and medium size protein complexes: RANTES complexed with a CCR5 N-terminal peptide.
    Abayev M; Srivastava G; Arshava B; Naider F; Anglister J
    FEBS J; 2017 Feb; 284(4):586-601. PubMed ID: 28052516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Synthesis of Sulfated CCR5 Peptide Surrogates and their Use to Study Receptor-Ligand Interactions.
    Naider F; Anglister J
    Protein Pept Lett; 2018; 25(12):1124-1136. PubMed ID: 30381052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.
    Schnur E; Noah E; Ayzenshtat I; Sargsyan H; Inui T; Ding FX; Arshava B; Sagi Y; Kessler N; Levy R; Scherf T; Naider F; Anglister J
    J Mol Biol; 2011 Jul; 410(5):778-97. PubMed ID: 21763489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.
    Bannert N; Craig S; Farzan M; Sogah D; Santo NV; Choe H; Sodroski J
    J Exp Med; 2001 Dec; 194(11):1661-73. PubMed ID: 11733580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of RANTES by extracellular parts of the CCR5 receptor.
    Duma L; Häussinger D; Rogowski M; Lusso P; Grzesiek S
    J Mol Biol; 2007 Jan; 365(4):1063-75. PubMed ID: 17101151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120.
    Moseri A; Akabayov SR; Cohen LS; Naider F; Anglister J
    FEBS J; 2022 Jun; 289(11):3132-3147. PubMed ID: 34921512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains.
    Schnur E; Kessler N; Zherdev Y; Noah E; Scherf T; Ding FX; Rabinovich S; Arshava B; Kurbatska V; Leonciks A; Tsimanis A; Rosen O; Naider F; Anglister J
    FEBS J; 2013 May; 280(9):2068-84. PubMed ID: 23480650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
    Stone MJ; Payne RJ
    Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern and temporal sequence of sulfation of CCR5 N-terminal peptides by tyrosylprotein sulfotransferase-2: an assessment of the effects of N-terminal residues.
    Jen CH; Moore KL; Leary JA
    Biochemistry; 2009 Jun; 48(23):5332-8. PubMed ID: 19402700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.
    Seibert C; Cadene M; Sanfiz A; Chait BT; Sakmar TP
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11031-6. PubMed ID: 12169668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region.
    Farzan M; Chung S; Li W; Vasilieva N; Wright PL; Schnitzler CE; Marchione RJ; Gerard C; Gerard NP; Sodroski J; Choe H
    J Biol Chem; 2002 Oct; 277(43):40397-402. PubMed ID: 12183462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties.
    Scurci I; Akondi KB; Pinheiro I; Paolini-Bertrand M; Borgeat A; Cerini F; Hartley O
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129753. PubMed ID: 32991968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
    Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
    EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of intermolecular transferred NOEs in large protein complexes using asymmetric deuteration: HIV-1 gp120 in complex with a CCR5 peptide.
    Srivastava G; Moseri A; Kessler N; Akabayov SR; Arshava B; Naider F; Anglister J
    FEBS J; 2016 Nov; 283(22):4084-4096. PubMed ID: 27701820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-terminal engineering of CXCL12 and CCL5 chemokines: functional characterization by electrophysiological recordings.
    Picciocchi A; Siaučiūnaiteė-Gaubard L; Petit-Hartlein I; Sadir R; Revilloud J; Caro L; Vivaudou M; Fieschi F; Moreau C; Vivès C
    PLoS One; 2014; 9(1):e87394. PubMed ID: 24498095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.